Literature DB >> 10385548

Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer.

M Jurado1, R Martínez-Monge, J García-Foncillas, I Azinovic, J Aristu, G López-García, A Brugarolas.   

Abstract

PURPOSE: The purpose of this study was to describe the feasibility of a combined preoperative chemoradiation program followed by radical surgery in advanced cervical cancer.
MATERIALS AND METHODS: From February 1988 to April 1997, 40 patients with carcinoma of the cervix were treated with preoperative external beam radiotherapy to 45 Gy in 5 weeks. Patients received concurrent continuous infusion cisplatin (20 mg/m2) and 5-fluorouracil (1500 mg) chemotherapy during the first (days 1-4) and fifth (days 22-25) weeks of the radiation course. Radical surgery was performed 4-6 weeks after the completion of the preoperative treatment. Intraoperative radiotherapy was given to 20 patients, based on intraoperative assessment.
RESULTS: Toxicity associated with chemoradiation was usually mild except in two patients who presented WHO grade 4 bone marrow aplasia. Three patients developed postoperative ureterovaginal fistula, and five patients developed long-term hydronephrosis that needed ureteral stenting. Clinical response was observed in 95% of the patients (55% complete response). The analysis of the surgical specimens revealed complete pathological response in 67.5% of the cases and partial pathological response in 32.5%. As expected, the degree of pathological response was predicted by the degree of clinical response (P = 0.001). Nine-year local control, distant metastases-free survival, disease-free survival, and overall survival were 86, 84, 81, and 85%, respectively. Patients displaying a complete pathological response had statistically significant improved local control (P = 0.004), distant metastases-free survival (P = 0.009), disease-free survival (P = 0.002), and overall survival (P = 0.038).
CONCLUSIONS: Cisplatin plus 5-fluorouracil preoperative chemoradiation is active and usually well tolerated in locally advanced carcinoma of cervix, inducing a high rate of clinical and pathological complete responses. When this therapy is followed by radical surgery, the local control rates are excellent, even in patients with advanced stages or poor response. These improved local control rates may be achievable only through extensive surgical resection, with a parallel increase in the complication rates. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10385548     DOI: 10.1006/gyno.1999.5424

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  12 in total

1.  A preliminary results of a randomized trial comparing monthly 5-flourouracil and cisplatin to weekly cisplatin alone combined with concurrent radiotherapy for locally advanced cervical cancer.

Authors:  Young Seok Kim; Seong Soo Shin; Eun Kyung Choi; Jong Hoon Kim; Seung Do Ahn; Sang-wook Lee; Heon-Jin Park; Young-Tak Kim; Jung-Eun Mok; Joo-Hyun Nam
Journal:  Cancer Res Treat       Date:  2005-02-28       Impact factor: 4.679

2.  Neuropilin-1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer.

Authors:  Alessandra Battaglia; Alexia Buzzonetti; Giovanni Monego; Laura Peri; Gabriella Ferrandina; Francesco Fanfani; Giovanni Scambia; Andrea Fattorossi
Journal:  Immunology       Date:  2007-11-20       Impact factor: 7.397

3.  Pre-operative Concomitant Radio-chemotherapy in Bulky Carcinoma of the Cervix: A Single Institution Study.

Authors:  Anne de la Rochefordiere; Youlia Kirova; Severine Alran; Corine Plancher; Virginie Fourchotte; Philippe Beuzeboc; Vincent de Margerie; Peter Petrow; Xavier Sastre-Garau; Vincent Servois; Suzy Scholl; Paul Cottu; Laurent Mignot; Patricia de Cremoux; Remy Salmon
Journal:  Clin Med Oncol       Date:  2008-03-27

4.  Prognostic significance of pathological response after neoadjuvant chemotherapy or chemoradiation for locally advanced cervical carcinoma.

Authors:  Myrna Candelaria; José Chanona-Vilchis; Lucely Cetina; Diana Flores-Estrada; Carlos López-Graniel; Aaron González-Enciso; David Cantú; Adela Poitevin; Lesbia Rivera; Jose Hinojosa; Jaime de la Garza; Alfonso Dueñas-Gonzalez
Journal:  Int Semin Surg Oncol       Date:  2006-02-03

5.  Radiation-sparing managements for cervical cancer: a developing countries perspective.

Authors:  Myrna Candelaria; Lucely Cetina; Alicia Garcia-Arias; Carlos Lopez-Graniel; Jaime de la Garza; Elizabeth Robles; Alfonso Duenas-Gonzalez
Journal:  World J Surg Oncol       Date:  2006-11-13       Impact factor: 2.754

6.  Potential implications of GRP58 expression and susceptibility of cervical cancer to cisplatin and thymoquinone-based therapy.

Authors:  Wan Abd Ghani Wan Nor Hafiza; Saiful Yazan Latifah
Journal:  Onco Targets Ther       Date:  2014-08-07       Impact factor: 4.147

7.  Brachytherapy versus radical hysterectomy after external beam chemoradiation: a non-randomized matched comparison in IB2-IIB cervical cancer patients.

Authors:  Lucely Cetina; Alicia Garcia-Arias; Myrna Candelaria; David Cantú; Lesbia Rivera; Jaime Coronel; Blanca Bazan-Perkins; Vladimir Flores; Aaron Gonzalez; Alfonso Dueñas-González
Journal:  World J Surg Oncol       Date:  2009-02-16       Impact factor: 2.754

8.  Polarisation of Tumor-Associated Macrophages toward M2 Phenotype Correlates with Poor Response to Chemoradiation and Reduced Survival in Patients with Locally Advanced Cervical Cancer.

Authors:  Marco Petrillo; Gian Franco Zannoni; Enrica Martinelli; Luigi Pedone Anchora; Gabriella Ferrandina; Giovanna Tropeano; Anna Fagotti; Giovanni Scambia
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

9.  The Effect of Extrafascial Hysterectomy After Completion of External Beam Radiotherapy for Treatment of Locally Advanced Stages (IIB-III) of Cervical Cancer.

Authors:  Zahra Sarraf; Bahareh Hamedi; Soodabeh Hooshmand; Ahmad Mosalaie; Minoo Robati; Mozhdeh Momtahan; Pouya Farhadi
Journal:  Iran Red Crescent Med J       Date:  2013-12-05       Impact factor: 0.611

10.  Chemoradiotherapy in combination with radical surgery is associated with better outcome in cervical cancer patients.

Authors:  Dan Zheng; Hua-Ping Mou; Peng Diao; Xiao-Ming Li; Chuan-Li Zhang; Jing Jiang; Jia-Lian Chen; Li-Shuai Wang; Qiu Wang; Guang-Yuan Zhou; Jie Chen; Chuan Lin; Zhi-Ping Yuan
Journal:  Oncotarget       Date:  2017-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.